Faye H. Cooles
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Rheumatoid arthritis and osteoarthritis patients demonstrate comparable rates of major adverse cardiovascular events: a single-centre retrospective cohort study.
Journal: Rheumatology advances in practice
Published: December 07, 2025
Early onset neutropenia in rituximab treated rheumatoid arthritis patients: a case series.
Journal: Rheumatology advances in practice
Published: September 02, 2025
Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti-Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 14, 2024
Role of IFN-α in Rheumatoid Arthritis.
Journal: Current rheumatology reports
Published: November 07, 2023
Precision medicine: the precision gap in rheumatic disease.
Journal: Nature reviews. Rheumatology
Published: September 07, 2022
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Journal: Annals of the rheumatic diseases
Published: February 16, 2022
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease.
Journal: The Lancet. Rheumatology
Published: May 01, 2021
Excess Mucin Impairs Subglottic Epithelial Host Defense in Mechanically Ventilated Patients.
Journal: American journal of respiratory and critical care medicine
Published: February 10, 2018
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
Journal: Frontiers in immunology
Published: October 21, 2017
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy.
Journal: The Journal of allergy and clinical immunology
Published: December 22, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies.
Journal: Arthritis research & therapy
Published: August 18, 2016
Last Updated: 09/26/2026